Skip to content

Clinical trials

Phase 2 Hepatitis B trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B Phase: Phase 2 Country / region: Italy Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20101
20141
20181
20201
20213
20221
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting4
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline6
Gilead Sciences2
Aligos Therapeutics1
AusperBio Therapeutics Inc.1
Bristol-Myers Squibb1
Instituto Grifols, S.A.1
Janssen Research & Development, LLC1
Janssen Sciences Ireland UC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B14
Hepatitis B, Chronic9
Hepatitis2
Acquired Immunodeficiency Syndrome1
Blood-Borne Infections1
Chronic Disease1
Communicable Diseases1
DNA Virus Infections1
Digestive System Diseases1
Disease Attributes1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.